Trademark: 97054481
Word
ZETAMET
Status
Pending
Status Code
732
Status Date
Tuesday, February 20, 2024
Serial Number
97054481
Mark Type
4000
Filing Date
Thursday, September 30, 2021
Published for Opposition
Tuesday, August 2, 2022

Trademark Owner History
Zetagen Therapeutics, Inc. - Owner At Publication

Classifications
5 Pharmaceutical products for the treatment of bone diseases; pharmaceutical preparations for the treatment of metastatic tumors and lesions; Pharmaceuticals, namely, for destroying, inhibiting or preventing the spread of uncontrolled growth of abnormal tissues, namely, metastatic tumors and lesions

Trademark Events
Feb 21, 2024
Notice Of Approval Of Extension Request E-Mailed
Feb 20, 2024
Sou Extension 3 Granted
Feb 20, 2024
Sou Extension 3 Filed
Feb 20, 2024
Sou Teas Extension Received
Nov 7, 2023
Assigned To Examiner
Sep 16, 2023
Notice Of Approval Of Extension Request E-Mailed
Sep 14, 2023
Sou Extension 2 Granted
Sep 14, 2023
Sou Extension 2 Filed
Sep 14, 2023
Sou Teas Extension Received
Mar 11, 2023
Notice Of Approval Of Extension Request E-Mailed
Mar 9, 2023
Sou Extension 1 Granted
Mar 9, 2023
Sou Extension 1 Filed
Mar 9, 2023
Sou Teas Extension Received
Sep 27, 2022
Noa E-Mailed - Sou Required From Applicant
Aug 2, 2022
Official Gazette Publication Confirmation E-Mailed
Aug 2, 2022
Published For Opposition
Jul 13, 2022
Notification Of Notice Of Publication E-Mailed
Jun 30, 2022
Approved For Pub - Principal Register
Jun 30, 2022
Assigned To Examiner
Oct 28, 2021
New Application Office Supplied Data Entered
Oct 4, 2021
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24